Buckingham Research Upgrades Imperva (IMPV) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts IMPV Hot Sheet
Price: $55.74 --0%
Rating Summary:
10 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 92
Rating Summary:
10 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 92
Join SI Premium – FREE
Buckingham Research upgraded Imperva (NYSE: IMPV) from Neutral to Buy with a price target of $70.00.
For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.
Shares of Imperva closed at $57.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Securities Upgrades Canadian Utilities (CU:CN) (CDUAF) to Buy
- BNP Paribas Exane Upgrades Kroger (KR) to Outperform
- Wolfe Research Upgrades Old Dominion Freight Line (ODFL) to Peerperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
Buckingham ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
